Pfizer sticks to forecast after Q1 profit boost

Business / 28 Apr

Mylan, Pfizer delay merger due to Covid-19 outbreak

Business / 26 Mar

Pfizer beats profit estimates, ups earnings forecast

Business / 29 Oct 19

Purdue deal to rank among biggest in pharma history

Business / 16 Sep 19

Mylan to combine with Pfizer's off-patent drugs unit

Business / 29 Jul 19

Pfizer buys cancer drug developer Array for $10.64 bn

Business / 17 Jun 19

Pfizer workers to strike in dispute over pension change

Munster / 31 Jan 19

Pfizer forecasts 2019 revenue and profit below targets

Business / 29 Jan 19

GSK and Pfizer to combine consumer health businesses

Business / 19 Dec 18

Pfizer cuts revenue forecast

Business / 30 Oct 18

Pfizer set to split company into three units

Business / 11 Jul 18

Pfizer sales miss as breast cancer drug disappoints

Business / 01 May 18

GSK buys Novartis stake in consumer healthcare venture

Business / 27 Mar 18

GSK pulls out of $20 billion race for Pfizer asset

Business / 23 Mar 18

Biogen to buy Pfizer's neurology drug for almost $600m

Business / 12 Mar 18

Pfizer books $11 billion tax gain

Business / 30 Jan 18

PAC told TV licence fee system is broken

News / 09 Nov 17

Pfizer doubles Q3 profits, raises full-year forecast

Business / 31 Oct 17

Pfizer weighs sale of consumer healthcare business

Business / 11 Oct 17

Pfizer revenue misses estimates as top drugs disappoint

Business / 02 May 17

Pfizer's quarterly profit misses estimates

Business / 31 Jan 17

Trial treatment delays breast cancer development

News / 13 Dec 16

Drug firms fined over epilepsy drug price hike

News / 07 Dec 16

UK fines Pfizer record £84m for huge price hike

Business / 07 Dec 16

Pfizer cancels €400m plant expansion in Dublin

News / 26 Nov 16